What's new

Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised

Mar 19, 2025 - 15:59
 0
Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Rasagiline ratiopharm, rasagiline, Date of authorisation: 12/01/2015, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

FT: China delays approval of BYD Mexico plant over US fears

Next Article

NorthStar Clean Energy secures US$334 million for 250MW Michigan PV

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Lutathera, lutetium (177Lu) oxodotreotide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0461/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

Veterinary medicines European public assessment report (EPAR): Omeprazole TriviumVet, omeprazole, Drugs for acid related disorders, Status: Opinion

Veterinary medicines European public assessment report ...

Feb 14, 2025  0

PSUSA/00000048/202406

PSUSA/00000048/202406

Mar 7, 2025  0